4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)

G.G. Steger; R. Greil; R. Jakesz; A. Lang; B. Mlineritsch; E. Melbinger-Zeinitzer; C. Marth; H. Samonigg; E. Kubista; M. Gnant

doi:10.1016/s1359-6349(09)72030-0

4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)72030-0 ◽

2009 ◽

Vol 7 (3) ◽

pp. 3 ◽

Cited By ~ 11

Author(s):

G.G. Steger ◽

R. Greil ◽

R. Jakesz ◽

A. Lang ◽

B. Mlineritsch ◽

...

Keyword(s):

Breast Cancer ◽

Colorectal Cancer ◽

Early Breast Cancer ◽

Neoadjuvant Treatment ◽

Phase Iii ◽

Study Group ◽

Cancer Study Group ◽

First Results ◽

Phase Iii Study ◽

Group Trial

Download Full-text

Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8.

10.1158/0008-5472.sabcs-14 ◽

2009 ◽

Cited By ~ 11

Author(s):

R Jakesz ◽

M Gnant ◽

R Griel ◽

C Tausch ◽

H Samonigg ◽

...

Keyword(s):

Breast Cancer ◽

Colorectal Cancer ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Sequencing Strategy ◽

Group Trial

Download Full-text

Zoledronic Acid Prevents Bone Loss in Premenopausal Women with Early Breast Cancer Undergoing Adjuvant Chemotherapy: A Phase III Study of Korean Cancer Study Group (KCSG-BR06-01).

10.1158/0008-5472.sabcs-09-2104 ◽

2009 ◽

Author(s):

J. Ahn ◽

K. Jung ◽

S. Kim ◽

K. Lee ◽

J. Ro ◽

...

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Adjuvant Chemotherapy ◽

Bone Loss ◽

Early Breast Cancer ◽

Premenopausal Women ◽

Phase Iii ◽

Study Group ◽

Cancer Study Group ◽

Phase Iii Study

Download Full-text

Abstract P1-08-13: Predictive value of intrinsic luminal subtypes in premenopausal women with endocrine-responsive early breast cancer: Results from Austrian breast and colorectal cancer study group trial 5

10.1158/0008-5472.sabcs13-p1-08-13 ◽

2013 ◽

Author(s):

Z Bago-Horvath ◽

M Rudas ◽

R Jakesz ◽

R Greil ◽

O Dietze ◽

...

Keyword(s):

Breast Cancer ◽

Colorectal Cancer ◽

Early Breast Cancer ◽

Predictive Value ◽

Premenopausal Women ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Group Trial

Download Full-text

A randomized trial comparing axillary clearance versus no axillary clearance in older patients (≥ 60 years) with breast cancer: First results of International Breast Cancer Study Group Trial 10–93

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.505 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 505-505

Author(s):

S. B. Holmberg ◽

D. Crivellari ◽

D. Zahrieh ◽

J. F. Forbes ◽

P. Rey ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Older Patients ◽

Study Group ◽

Axillary Clearance ◽

Cancer Study ◽

Cancer Study Group ◽

Breast Cancer Study ◽

First Results ◽

Group Trial

Download Full-text

Phase III study comparing vinorelbine/gemcitabine with vinorelbine/carboplatin as first-line chemotherapy of advanced NSCLC: A Norwegian Lung Cancer Study Group trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7597 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7597-7597 ◽

Cited By ~ 1

Author(s):

Ø. Fløtten ◽

R. M. Bremnes ◽

B. H. Grønberg ◽

S. Sundstrøm ◽

T. Amundsen ◽

...

Keyword(s):

Lung Cancer ◽

Advanced Nsclc ◽

Phase Iii ◽

Study Group ◽

First Line ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Phase Iii Study ◽

Group Trial ◽

Line Chemotherapy

Download Full-text

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Annals of Oncology ◽

10.1093/annonc/mdu544 ◽

2015 ◽

Vol 26 (2) ◽

pp. 313-320 ◽

Cited By ~ 165

Author(s):

M. Gnant ◽

B. Mlineritsch ◽

H. Stoeger ◽

G. Luschin-Ebengreuth ◽

M. Knauer ◽

...

Keyword(s):

Breast Cancer ◽

Colorectal Cancer ◽

Zoledronic Acid ◽

Endocrine Therapy ◽

Ovarian Function ◽

Final Analysis ◽

Study Group ◽

Ovarian Function Suppression ◽

Cancer Study Group ◽

Group Trial

Download Full-text

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

Annals of Oncology ◽

10.1093/annonc/mdt508 ◽

2014 ◽

Vol 25 (2) ◽

pp. 366-371 ◽

Cited By ~ 41

Author(s):

G.G. Steger ◽

R. Greil ◽

A. Lang ◽

M. Rudas ◽

F. Fitzal ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Neoadjuvant Treatment ◽

Phase Iii ◽

Phase Iii Study

Download Full-text

Final Results of ABCSG-24, a Randomized Phase III Study Comparing Epirubicin, Docetaxel, and Capecitabine (EDC) to Epirubicin and Docetaxel (ED) as Neoadjuvant Treatment for Early Breast Cancer and Comparing ED/EDC + Trastuzumab (T) to ED/EDC as Neoadjuvant Treatment for Early HER-2 Positive Breast Cancer.

10.1158/0008-5472.sabcs-09-1081 ◽

2009 ◽

Cited By ~ 3

Author(s):

G. Steger ◽

R. Greil ◽

R. Jakesz ◽

A. Lang ◽

B. Mlineritsch ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Neoadjuvant Treatment ◽

Phase Iii ◽

Phase Iii Study ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Abstract P4-09-02: Prognostic and Predictive Value of Centrally Reviewed Ki67 Labeling Index in Postmenopausal Women with Endocrine-Responsive Breast Cancer: Results from Austrian Breast and Colorectal Cancer Study Group Trial 8

10.1158/0008-5472.sabcs10-p4-09-02 ◽

2010 ◽

Author(s):

Z Bago-Horvath ◽

M Rudas ◽

R Jakesz ◽

P Dubsky ◽

CF Singer ◽

...

Keyword(s):

Breast Cancer ◽

Colorectal Cancer ◽

Postmenopausal Women ◽

Predictive Value ◽

Labeling Index ◽

Study Group ◽

Cancer Study ◽

Ki67 Labeling Index ◽

Cancer Study Group ◽

Group Trial

Download Full-text

A randomized trial comparing axillary clearance versus no axillary clearance in older patients (≥ 60 years) with breast cancer: First results of International Breast Cancer Study Group Trial 10–93

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.505 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 505-505 ◽

Cited By ~ 1

Author(s):

S. B. Holmberg ◽

D. Crivellari ◽

D. Zahrieh ◽

J. F. Forbes ◽

P. Rey ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Older Patients ◽

Study Group ◽

Axillary Clearance ◽

Cancer Study ◽

Cancer Study Group ◽

Breast Cancer Study ◽

First Results ◽

Group Trial

Download Full-text